UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM Free Cash Flow margin
32.6%
5Y avg
30.5%
Biotechnology industry median
(753.4%)
Stock quality & Intrinsic value
8/10
0.2% undervalued

United Therapeutics Corporation Free Cash Flow margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
UTHR
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Free Cash Flow margin
21.1%
32.4%
22.6%
4.9%
(61.7%)
0.6%
31.9%
28.8%
23.1%
35.2%
23.9%
22.7%
37.6%
22.5%
36.5%
(20.0%)
46.9%
28.3%
34.3%
32.1%
UTHR
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for UTHR and see if it's the right time to invest.
Dive in

United Therapeutics Corporation (UTHR) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

UTHR key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is United Therapeutics Corporation's Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 32.6%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for United Therapeutics Corporation have been 33.9% over the past three years, and 32.0% over the past five years.

2) Is United Therapeutics Corporation's Free Cash Flow margin Good?

As of today, United Therapeutics Corporation's Free Cash Flow margin is 32.6%, which is higher than industry median of (753.4%). It indicates that United Therapeutics Corporation's Free Cash Flow margin is Good.

3) How does United Therapeutics Corporation's Free Cash Flow margin compare to its peers?

As of today, United Therapeutics Corporation's Free Cash Flow margin is 32.6%, which is higher than peer median of 0.6%. The list of peers includes GMAB, BNTX, NVO, REGN, ALNY, INCY, ARGX, VRTX, BGNE, MRNA.